3-ethynylaniline

C#Cc1cccc(NC(=O)CCCC(=O)O)c1
Reaction #47736
product
수율 99.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
C#Cc1cccc(NS(C)(=O)=O)c1
Reaction #66503
methanesulfonamide
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_09
C#Cc1cccc(Nc2ncnc3sc4c(c23)CN(C(=O)OCC)C4)c1
Reaction #66805
title compound
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_09
C#Cc1cccc(Nc2ncnc3oc4c(c23)CCN(C(=O)OCC)C4)c1
Reaction #66814
title compound
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_09
C#Cc1cccc(Nc2ncnc3ccc4nc(C#N)sc4c23)c1
Reaction #90398
9-(3-Ethynylphenylamino)thiazolo[5,4-f]quinazoline-2-carbonitrile
수율 84.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2016_09
C#Cc1cccc(NC(=O)c2cc(C(N)=O)ccc2OC)c1
Reaction #183162
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
C#Cc1cccc(Nc2ncnc3[nH]cc(C(=O)O)c23)c1
Reaction #189474
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
C#Cc1cccc(Nc2ncnc3c2ccn3CCOCCOC)c1
Reaction #241936
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
C#Cc1cccc(NC(=O)c2cc(C)nn2C)c1
Reaction #244133
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Cl
Reaction #251363
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Cl
Reaction #261337
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
C#Cc1cccc(Nc2ncnc3c2ccn3CC=C)c1
Reaction #267320
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
CC(C)(O)C#Cc1cccc([N+](=O)[O-])c1
Reaction #270758
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
C#Cc1cccc(NC(C)=O)c1
Reaction #274281
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
C#Cc1cccc(NS(C)(=O)=O)c1
Reaction #325338
methanesulfonamide
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl
Reaction #326175
erlotinib hydrochloride
수율 88.8%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl
Reaction #326176
erlotinib hydrochloride
수율 84.4%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl
Reaction #326177
erlotinib base
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl
Reaction #326178
erlotinib base
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl
Reaction #326179
erlotinib base
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
1 페이지다음 페이지